Heller, J. H., Spiridigliozzi, G. A., Doraiswamy, P. M., Sullivan, J. A., Crissman, B. G., & Kishnani, P. S. (2004). Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial. Am J Med Genet A, 130A(3), 325–326. https://doi.org/10.1002/ajmg.a.30184

Heller, James H., Gail A. Spiridigliozzi, P Murali Doraiswamy, Jennifer A. Sullivan, Bythe G. Crissman, and Priya S. Kishnani. “Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial.” Am J Med Genet A 130A, no. 3 (October 15, 2004): 325–26. https://doi.org/10.1002/ajmg.a.30184.

Heller JH, Spiridigliozzi GA, Doraiswamy PM, Sullivan JA, Crissman BG, Kishnani PS. Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial. Am J Med Genet A. 2004 Oct 15;130A(3):325–6.

Heller, James H., et al. “Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial.” Am J Med Genet A, vol. 130A, no. 3, Oct. 2004, pp. 325–26. Pubmed, doi:10.1002/ajmg.a.30184.

Heller JH, Spiridigliozzi GA, Doraiswamy PM, Sullivan JA, Crissman BG, Kishnani PS. Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial. Am J Med Genet A. 2004 Oct 15;130A(3):325–326.